No evidence for IgE receptor FcεRI expression on bronchial epithelial cells of asthmatic patients

No evidence for IgE receptor FcεRI expression on bronchial epithelial cells of asthmatic patients

Immunoglobulin E (IgE) plays an important role in the pathogenesis of asthma and anti-IgE therapy was approved for treating patients with severe persistent allergic asthma. The exact target sites of anti-IgE therapy are not well characterized; however, it has been proposed that the therapeutic effec...

Full description

Bibliographic Details
Main Authors: Omer Qibi, Severine Audusseau, Andrea Mogas, Zoulfia Allakhverdi, Abdelilah Soussi Gounni, Saba Al Heialy, Qutayba Hamid
Format: Article
Language:English
Published: American Institute of Mathematical Sciences 2018-11-01
Series:AIMS Allergy and Immunology
Subjects:
immunoglobulin E| high-affinity receptor FcεRI| severe asthma| airway inflammation| airway remodeling
Online Access:http://www.aimspress.com/article/10.3934/Allergy.2018.4.165/fulltext.html

Internet

http://www.aimspress.com/article/10.3934/Allergy.2018.4.165/fulltext.html

Similar Items